Home › USFDA Tracker › Shilpa Medicare

Shilpa Medicare — USFDA Status

Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Shilpa Medicare (NSE: SHILPAMED, BSE: 530549), from US FDA records and exchange filings.

66
Compliance score (5 years) · how
5
USFDA-inspected plants on record
0
OAI classifications (5y)
1
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified NAI — 14 Mar 2025 (Chicksugur, Raichur plant). Source: FDA Data Dashboard.
USFDA events by year
2021
2023
2024
2025
NAIVAIForm 483OAIWarning letterImport alertUS approval

Plants

PlantFEILatest resultLast inspectionHistory (newest first)
Chicksugur, Raichur
Shilpa Pharma Lifesciences Limited
3007197995 NAI 14 Mar 2025
Deosugur
Shilpa Pharma Lifesciences Limited
3025560903 VAI 07 Mar 2025
Dabaspet, Bengaluru
Shilpa Medicare Limited
3018694237 VAI 30 Oct 2024
Hyderbad
Shilpa Medicare Limited
3030542761 NAI 01 Mar 2024
Hyderabad
Shilpa Medicare Limited
3019773458 VAI 10 Mar 2023

Full USFDA timeline

14 Mar 2025
NAI — clean
USFDA inspection classified NAI
Chicksugur, Raichur · FEI 3007197995 · Shilpa Pharma Lifesciences Limited, Chicksugur, Raichur — Drug Quality Assurance (Drugs)
07 Mar 2025
VAI — minor issues
USFDA inspection classified VAI
Deosugur · FEI 3025560903 · Shilpa Pharma Lifesciences Limited, Deosugur — Drug Quality Assurance (Drugs)
30 Oct 2024
Form 483
Form 483: 2 observations
Dabaspet, Bengaluru · FEI 3018694237 · Calibration/Inspection/Checking not done; Signature and checking of records -- 2 persons
30 Oct 2024
VAI — minor issues
USFDA inspection classified VAI
Dabaspet, Bengaluru · FEI 3018694237 · Shilpa Medicare Limited, Dabaspet, Bengaluru — Drug Quality Assurance (Drugs)
01 Mar 2024
NAI — clean
USFDA inspection classified NAI
Hyderbad · FEI 3030542761 · Shilpa Medicare Limited, Hyderbad — Bioresearch Monitoring (Drugs)
10 Mar 2023
VAI — minor issues
USFDA inspection classified VAI
Hyderabad · FEI 3019773458 · Shilpa Medicare Limited, Hyderabad — Drug Quality Assurance (Drugs)
16 Feb 2021
Import alert
Added to FDA import alert 66-40
Shilpa Medicare Limited, Plot No. S20 to S26, Pharmaceutical Formulations SEZ, TSIIC Green Industrial Park, Polepally (Village), Jadcherla, Mahabubnagar District, Telangana INDIA
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/shilpa